Russell Moore

482 total citations
7 papers, 363 citations indexed

About

Russell Moore is a scholar working on Oncology, Internal Medicine and Surgery. According to data from OpenAlex, Russell Moore has authored 7 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Internal Medicine and 2 papers in Surgery. Recurrent topics in Russell Moore's work include Venous Thromboembolism Diagnosis and Management (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers) and Cancer Treatment and Pharmacology (2 papers). Russell Moore is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers) and Cancer Treatment and Pharmacology (2 papers). Russell Moore collaborates with scholars based in United States and Portugal. Russell Moore's co-authors include Hani Hassoun, Rekha Parameswaran, Nelly G. Adel, Gerald A. Soff, Elyn Riedel, Manisha Bhutani, Darren R. Feldman, Richard D. Carvajal, Carol L. Chen and Mary S. Brady and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Russell Moore

6 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Russell Moore United States	4	222	201	100	79	60	7	363
G.-F. von Tempelhoff Germany	9	153 0.7×	99 0.5×	54 0.5×	24 0.3×	53 0.9×	24	366
V. Milesi Italy	2	131 0.6×	77 0.4×	59 0.6×	25 0.3×	43 0.7×	3	252
W. Åberg Sweden	10	309 1.4×	228 1.1×	16 0.2×	54 0.7×	155 2.6×	12	477
Caspar Wiener Austria	4	69 0.3×	43 0.2×	174 1.7×	29 0.4×	96 1.6×	5	333
Wanda M. Hinshaw United States	6	120 0.5×	77 0.4×	40 0.4×	37 0.5×	102 1.7×	9	335
Michael M. Farooq United States	11	107 0.5×	88 0.4×	14 0.1×	78 1.0×	150 2.5×	22	376
Samuel Rodriguez United States	7	46 0.2×	205 1.0×	38 0.4×	9 0.1×	219 3.6×	11	413
Arie J. Verschoor Netherlands	11	49 0.2×	90 0.4×	64 0.6×	6 0.1×	40 0.7×	18	376
Hui‐Li Gan China	10	68 0.3×	185 0.9×	37 0.4×	4 0.1×	65 1.1×	24	305
O. R. van Reenen South Africa	8	44 0.2×	77 0.4×	21 0.2×	11 0.1×	102 1.7×	16	337

Countries citing papers authored by Russell Moore

Since Specialization

Citations

This map shows the geographic impact of Russell Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell Moore more than expected).

Fields of papers citing papers by Russell Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell Moore. The network helps show where Russell Moore may publish in the future.

Co-authorship network of co-authors of Russell Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Russell Moore. A scholar is included among the top collaborators of Russell Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell Moore. Russell Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Moore, Russell, et al.. (2019). Retrospective analysis of the efficacy and safety of neoadjuvant gemcitabine and cisplatin in muscle-invasive bladder cancer. Journal of Oncology Pharmacy Practice. 26(2). 330–337. 3 indexed citations

2.

Moore, Russell, et al.. (2017). Incidence of skeletal related events in patients with bone metastasis receiving denosumab every four weeks compared to intervals greater than every four weeks. Journal of Oncology Pharmacy Practice. 25(3). 529–534. 2 indexed citations

3.

Khan, Shaheer, Carol L. Chen, Mary S. Brady, et al.. (2012). Unstable Angina Associated With Cisplatin and Carboplatin in a Patient With Advanced Melanoma. Journal of Clinical Oncology. 30(18). e163–e164. 24 indexed citations

4.

Moore, Russell, Nelly G. Adel, Elyn Riedel, et al.. (2011). High Incidence of Thromboembolic Events in Patients Treated With Cisplatin-Based Chemotherapy: A Large Retrospective Analysis. Journal of Clinical Oncology. 29(25). 3466–3473. 323 indexed citations

5.

Moore, Russell, Nelly G. Adel, Manisha Bhutani, et al.. (2009). Cisplatin-Based Chemotherapy Is Associated with An Unacceptably High Incidence of Thromboembolic Events: A Large Retrospective Analysis.. Blood. 114(22). 456–456. 2 indexed citations

6.

Buchholz, Thomas A., Russell Moore, Marsha D. McNeese, et al.. (1999). 160 Importance of radiation therapy for high-risk breast cancer patients treated with high-dose chemotherapy and stem cell transplant. International Journal of Radiation Oncology*Biology*Physics. 45(3). 230–230.

7.

Serra, J, Renate L. Soulen, Russell Moore, & Kym McNicholas. (1986). Interrupted aortic arch associated with Pourfour du Petit syndrome.. Thorax. 41(3). 217–218. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact